Susquehanna International Group’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109K Sell
48,428
-51,768
-52% -$116K ﹤0.01% 5857
2025
Q1
$214K Buy
100,196
+9,169
+10% +$19.6K ﹤0.01% 5448
2024
Q4
$220K Sell
91,027
-43,346
-32% -$105K ﹤0.01% 5174
2024
Q3
$328K Buy
134,373
+8,545
+7% +$20.9K ﹤0.01% 4184
2024
Q2
$323K Sell
125,828
-218,610
-63% -$562K ﹤0.01% 4116
2024
Q1
$1.01M Buy
344,438
+298,522
+650% +$872K ﹤0.01% 2649
2023
Q4
$106K Buy
45,916
+32,848
+251% +$75.9K ﹤0.01% 5323
2023
Q3
$34.1K Sell
13,068
-74,435
-85% -$194K ﹤0.01% 5186
2023
Q2
$313K Buy
87,503
+73,314
+517% +$262K ﹤0.01% 4173
2023
Q1
$30.9K Sell
14,189
-171,417
-92% -$374K ﹤0.01% 5539
2022
Q4
$2.23M Buy
185,606
+14,269
+8% +$172K ﹤0.01% 1508
2022
Q3
$1.11M Buy
171,337
+64,699
+61% +$419K ﹤0.01% 2395
2022
Q2
$488K Buy
106,638
+28,653
+37% +$131K ﹤0.01% 3384
2022
Q1
$675K Sell
77,985
-38,423
-33% -$333K ﹤0.01% 3332
2021
Q4
$1.66M Buy
116,408
+99,976
+608% +$1.43M ﹤0.01% 2192
2021
Q3
$361K Buy
16,432
+4,430
+37% +$97.3K ﹤0.01% 4092
2021
Q2
$161K Sell
12,002
-56,303
-82% -$755K ﹤0.01% 4937
2021
Q1
$694K Buy
+68,305
New +$694K ﹤0.01% 3450
2020
Q4
Hold
0
5161
2020
Q3
Hold
0
4819
2020
Q2
Hold
0
4723
2020
Q1
Sell
-13,628
Closed -$70K 4911
2019
Q4
$70K Sell
13,628
-1,176
-8% -$6.04K ﹤0.01% 3730
2019
Q3
$47K Buy
+14,804
New +$47K ﹤0.01% 4207
2018
Q1
Sell
-18,474
Closed -$166K 4197
2017
Q4
$166K Sell
18,474
-288
-2% -$2.59K ﹤0.01% 3205
2017
Q3
$185K Buy
+18,762
New +$185K ﹤0.01% 2772
2016
Q4
Hold
0
4571
2016
Q3
Hold
0
3655
2016
Q2
Hold
0
3829
2016
Q1
Hold
0
4229
2015
Q4
Sell
-10,972
Closed -$60K 4498
2015
Q3
$60K Buy
+10,972
New +$60K ﹤0.01% 4024
2015
Q2
Hold
0
4652
2015
Q1
Sell
-12,468
Closed -$57K 4372
2014
Q4
$57K Buy
12,468
+2,329
+23% +$10.6K ﹤0.01% 4254
2014
Q3
$82K Sell
10,139
-18,440
-65% -$149K ﹤0.01% 3720
2014
Q2
$275K Buy
28,579
+4,298
+18% +$41.4K ﹤0.01% 3601
2014
Q1
$282K Buy
+24,281
New +$282K ﹤0.01% 3010